Goldman Sachs Group Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $956,587 - $3.96 Million	3,416,384 Added 157.85%	5,580,702 $1.84 Million
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $1.55 Million - $2.44 Million	1,460,237 Added 207.4%	2,164,318 $2.51 Million
Q4 2023 Feb 13, 2024	SELL	$1.26 - $1.79 $379,784 - $539,534	-301,416 Reduced 29.98%	704,081 $1.19 Million
Q3 2023 May 14, 2024	BUY	$1.61 - $2.54 $485,279 - $765,596	301,416 Added 42.81%	1,005,497 $1.82 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $905,317 - $1.43 Million	562,309 Added 126.88%	1,005,497 $1.82 Million
Q2 2023 May 14, 2024	BUY	$1.14 - $1.95 $244,266 - $417,824	214,269 Added 93.6%	443,188 $824,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $244,266 - $417,824	214,269 Added 93.6%	443,188 $824,000
Q1 2023 May 14, 2024	SELL	$1.2 - $2.19 $1.52 Million - $2.77 Million	-1,263,778 Reduced 84.66%	228,919 $304,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $1.52 Million - $2.77 Million	-1,263,778 Reduced 84.66%	228,919 $304,000
Q4 2022 May 14, 2024	BUY	$1.63 - $3.52 $659,517 - $1.42 Million	404,612 Added 37.19%	1,492,697 $2.52 Million
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $659,517 - $1.42 Million	404,612 Added 37.19%	1,492,697 $2.52 Million
Q3 2022 May 14, 2024	SELL	$0.73 - $3.74 $2.3 Million - $11.8 Million	-3,156,165 Reduced 74.36%	1,088,085 $3.4 Million
Q3 2022 Nov 10, 2022	SELL	$0.73 - $3.74 $2.3 Million - $11.8 Million	-3,156,165 Reduced 74.36%	1,088,085 $3.39 Million
Q2 2022 May 14, 2024	BUY	$2.2 - $4.2 $7.79 Million - $14.9 Million	3,540,169 Added 502.81%	4,244,250 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $8.63 Million - $16.5 Million	3,924,356 Added 1226.77%	4,244,250 $10.1 Million
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $905,300 - $2.78 Million	319,894 New	319,894 $1.29 Million

Others Institutions Holding DNA

# of Institutions

Shares Held

48.1M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$394 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$21.6 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$14.1 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$10.7 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$2.2 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account